IndustryIntelligence | Biotechnology & Drugs

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$33	Subscribers Preview	2000	Analyst Call	Chiron; Schering	Paul Hastings
$38	Subscribers Preview	2002	Closing Remarks for Raymond V. Gilmartin Chairman, President and CEO, Merck & Co., Inc. at 2002 Annual Business Briefing	Merck & Co., Inc.
$39	Subscribers Preview	2003	Closing Remarks of Raymond V. Gilmartin, Chairman, President, and Chief Executive Officer, Merck & Co., Inc. at the 2003 Annual Business Briefing	Merck & Co., Inc.
$51	Subscribers Preview	2003	Conference Call	Cubist Pharmaceuticals Inc.
$46	Subscribers Preview	2003	Conference Call	Cubist Pharmaceuticals Inc.	Needham & Co., Inc.
$36	Subscribers	2002	Conference Call	Cubist Pharma; Gilead Sciences	Novartis
$46	Subscribers	2003	Conference Call	Akzo Nobel; Savient Pharma	TCG
$32	Subscribers	2002	Conference Call	Akzo Nobel N.V.	Savient Pharmaceuticals, Inc.
$34	Subscribers	2004	Conference Call Script	Theragenics Corp.
$40	Subscribers	2002	Conference Call Script	Inverness Medical Innovations Inc.
$42	Subscribers	2003	Conference Call Script	Savient Pharmaceuticals, Inc.	Technology General Corp.
$44	Subscribers Preview	2007	Conference Call Transcript	Cardinal Health, Inc.
$43	Subscribers Preview	2003	Conference Call Transcript	Abbott Labs; Akzo Nobel	Savient Pharma; Teva
$44	Subscribers	2006	Conference Call Transcript	Inhibitex, Inc.
$43	Subscribers Preview	2001	Conference Call Transcript	OXiGENE, Inc.
$43	Subscribers Preview	2006	Conference Call Transcript	Serologicals Corp.
$52	Subscribers	2004	Conference Call Transcript	Vion Pharmaceuticals, Inc.
$46	Subscribers Preview	2007	Conference Call Transcript	Vion Pharmaceuticals, Inc.
$37	Subscribers Preview	2004	Conference Call Transcript	Savient Pharmaceuticals, Inc.
$35	Subscribers Preview	2004	Conference Call Transcript	Savient Pharmaceuticals, Inc.